Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas.
Jimenez C, Subbiah V, Stephen B, Ma J, Milton D, Xu M, Zarifa A, Akhmedzhanov FO, Tsimberidou A, Habra MA, Rodon Anhert J, Fu S, Naing A.
Jimenez C, et al. Among authors: habra ma, ma j.
Cancers (Basel). 2020 Aug 16;12(8):2307. doi: 10.3390/cancers12082307.
Cancers (Basel). 2020.
PMID: 32824391
Free PMC article.